Haemolytic uraemic syndrome in a patient with acute lymphoblastic leukaemia, Pediatric Blood & Cancer, vol.55, pp.1402-1405, 2010. ,
Cancer-associated microangiopathic hemolytic anemia with thrombocytopenia: an important diagnostic consideration, European Journal of Haematology, vol.85, pp.43-50, 2010. ,
Genetics and outcome of atypical hemolytic uremic syndrome: a nationwide French series comparing children and adults, Clinical Journal of the American Society of Nephrology, vol.8, pp.554-562, 2013. ,
Cancerrelated microangiopathic hemolytic anemia: clinical and laboratory features in 168 reported cases, Medicine, vol.91, pp.195-205, 2012. ,
Terminal complement inhibitor eculizumab in atypical hemolytic-uremic syndrome, New England Journal of Medicine, vol.368, pp.2169-2181, 2013. ,
, British Medical Journal, vol.345, p.4565, 2012.
Relative role of genetic complement abnormalities in sporadic and familial aHUS and their impact on clinical phenotype, Clinical Journal of the American Society of Nephrology, vol.5, pp.1844-1859, 2010. ,
Successful use of eculizumab in a patient with post-transplant thrombotic microangiopathy, British Journal of Haematology, vol.161, pp.279-280, 2013. ,
Brief report: induction of sustained remission in recurrent catastrophic antiphospholipid syndrome via inhibition of terminal complement with eculizumab, Arthritis and Rheumatism, vol.64, pp.2719-2723, 2012. ,
Use of eculizumab for atypical haemolytic uraemic syndrome and C3 glomerulopathies, Nature Reviews. Nephrology, vol.8, pp.643-657, 2013. ,